[DPHARMA] YoY Annualized Quarter Result on 30-Sep-2011 [#3]

Announcement Date
21-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- 5.67%
YoY- 1.61%
Quarter Report
View:
Show?
Annualized Quarter Result
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Revenue 167,916 155,561 133,242 140,128 132,322 125,221 124,518 5.10%
PBT 43,452 41,356 35,064 35,856 35,736 39,473 42,305 0.44%
Tax -10,685 -9,122 -8,374 -8,686 -8,996 -9,621 -10,458 0.35%
NP 32,766 32,233 26,689 27,169 26,740 29,852 31,846 0.47%
-
NP to SH 32,766 32,233 26,689 27,169 26,740 29,852 31,846 0.47%
-
Tax Rate 24.59% 22.06% 23.88% 24.22% 25.17% 24.37% 24.72% -
Total Cost 135,149 123,328 106,553 112,958 105,582 95,369 92,672 6.48%
-
Net Worth 187,436 179,125 167,965 162,405 148,504 142,967 137,397 5.30%
Dividend
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Div 7,404 - - - - 111 14,803 -10.90%
Div Payout % 22.60% - - - - 0.37% 46.48% -
Equity
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Net Worth 187,436 179,125 167,965 162,405 148,504 142,967 137,397 5.30%
NOSH 138,841 138,856 138,814 138,807 138,788 138,803 138,785 0.00%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
NP Margin 19.51% 20.72% 20.03% 19.39% 20.21% 23.84% 25.58% -
ROE 17.48% 17.99% 15.89% 16.73% 18.01% 20.88% 23.18% -
Per Share
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 120.94 112.03 95.99 100.95 95.34 90.21 89.72 5.10%
EPS 23.60 23.21 19.23 19.57 19.27 21.51 22.95 0.46%
DPS 5.33 0.00 0.00 0.00 0.00 0.08 10.67 -10.91%
NAPS 1.35 1.29 1.21 1.17 1.07 1.03 0.99 5.30%
Adjusted Per Share Value based on latest NOSH - 138,763
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 17.44 16.16 13.84 14.56 13.75 13.01 12.93 5.11%
EPS 3.40 3.35 2.77 2.82 2.78 3.10 3.31 0.44%
DPS 0.77 0.00 0.00 0.00 0.00 0.01 1.54 -10.90%
NAPS 0.1947 0.1861 0.1745 0.1687 0.1543 0.1485 0.1427 5.31%
Price Multiplier on Financial Quarter End Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 -
Price 3.17 2.55 2.36 2.10 2.44 2.58 2.22 -
P/RPS 2.62 2.28 2.46 2.08 2.56 2.86 2.47 0.98%
P/EPS 13.43 10.99 12.27 10.73 12.66 12.00 9.67 5.62%
EY 7.44 9.10 8.15 9.32 7.90 8.34 10.34 -5.33%
DY 1.68 0.00 0.00 0.00 0.00 0.03 4.80 -16.04%
P/NAPS 2.35 1.98 1.95 1.79 2.28 2.50 2.24 0.80%
Price Multiplier on Announcement Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 21/11/14 19/11/13 23/11/12 21/11/11 26/11/10 20/11/09 19/11/08 -
Price 3.01 2.56 2.28 2.10 2.38 2.49 2.20 -
P/RPS 2.49 2.29 2.38 2.08 2.50 2.76 2.45 0.27%
P/EPS 12.75 11.03 11.86 10.73 12.35 11.58 9.59 4.85%
EY 7.84 9.07 8.43 9.32 8.10 8.64 10.43 -4.64%
DY 1.77 0.00 0.00 0.00 0.00 0.03 4.85 -15.45%
P/NAPS 2.23 1.98 1.88 1.79 2.22 2.42 2.22 0.07%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment